U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07805408) titled 'A Real World Study of Treatment Patterns and Effectiveness of Standard of Care in Primary Immune Thrombocytopenia Patients' on Sept. 01.
Brief Summary: The aim of this study was to describe real-world treatment patterns and standard of care treatment effectiveness and utilization outcomes in adult primary ITP patients indicated for second-line treatment with any prior corticosteroid treatment in real-world treatment settings in the United States (US) identified in an electronic health record (EHR) and claims database.
Study Start Date: May 16, 2025
Study Type: OBSERVATIONAL
Condition:
Immune Thrombocytopenia
Recruitment Status:...